|
|
|
|
|
|
by jcranmer
2755 days ago
|
|
|
If the pharmaceutical industry were willing to fake efficacy results, surely they could do better than having over ½ their drugs fail Phase III efficacy trials. Especially since one thing everyone agrees on is that the best way to lower drug costs is to figure out which drugs are going to fail Phase III much, much earlier. |
|
|